Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model.

J Med Chem · 2015 · PMC4610302 · PMID 25559213

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Nevertheless, these results confirm a highly significant involvement of the activation of ERβ in the antiproliferative effects of these compounds.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.